Dr. Katz describes how he uses social media to learn more about patient perceptions of cancer, how to decide which social media to use, and drawbacks to using social media in a professional capacity.
Matthew Katz, MD, director of radiation oncology at Lowell General Hospital, describes the session he chaired during the 2014 ASCO Annual Meeting on the use of social media by oncologists.
Dr. Katz discusses how he uses social media to learn more about patient perceptions of cancer, how to decide which outlets to utilize, and some of the drawbacks to using social media in a professional capacity.
Frontline Chemo-Free Regimen Supported in HR+/HER2+ Breast Cancer Therapy
January 1st 2024Combining anastrozole with palbociclib, trastuzumab, and pertuzumab as a frontline therapy for hormone receptor–positive, HER2-positive breast cancer may avoid some of the toxicities associated with chemotherapy, says Amy Tiersten, MD.
Frontline Chemo-Free Regimen Supported in HR+/HER2+ Breast Cancer Therapy
January 1st 2024Combining anastrozole with palbociclib, trastuzumab, and pertuzumab as a frontline therapy for hormone receptor–positive, HER2-positive breast cancer may avoid some of the toxicities associated with chemotherapy, says Amy Tiersten, MD.
2 Commerce Drive
Cranbury, NJ 08512